A two-drug, long-acting injectable regimen of HIV medications has demonstrated efficacy in maintaining HIV-1 viral suppression throughout almost two years of treatment. The results come from the ongoing LATTE-2 trial and were presented today at the 9th International AIDS Society (IAS) Conference on HIV Science, in Paris.

Visit Page